| 1 |
An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds
Samuel R. Nussbaum, Marissa Janine Carter, Caroline E. Fife et al. · Value in Health
Open access |
20 Sep 2017 |
1,224 |
| 2 |
Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease
Melanie Ann Felmlee, Robert S. Jones, Vivian Rodriguez‐Cruz et al. · Pharmacological Reviews
Open access |
6 Mar 2020 |
484 |
| 3 |
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Gilmar Reis et al. · The Lancet Global Health
Open access |
28 Oct 2021 |
405 |
| 4 |
The New Reconstructive Ladder: Modifications to the Traditional Model
Jeffrey E. Janis, Robert K. Kwon, Christopher E. Attinger · Plastic & Reconstructive Surgery
|
2011 |
275 |
| 5 |
Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
António Gonçalves, Julie Bertrand, Ruian Ke et al. · CPT Pharmacometrics & Systems Pharmacology
Open access |
18 Jun 2020 |
239 |
| 6 |
How COVID-19 has fundamentally changed clinical research in global health
Jay Park, Robin Mogg, Gerald E. Smith et al. · The Lancet Global Health
Open access |
16 Apr 2021 |
227 |
| 7 |
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy
Adam S. Darwich, Thomas M. Polasek, Jeffrey K Aronson et al. · The Annual Review of Pharmacology and Toxicology
ReviewOpen access |
9 Oct 2020 |
197 |
| 8 |
In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants
Monica Ramchandani, Dennis H. Robinson · Journal of Controlled Release
|
Jul 1998 |
194 |
| 9 |
Control of hepatocyte function on collagen foams: sizing matrix pores toward selective induction of 2-D and 3-D cellular morphogenesis
Colette S. Ranucci, Ajay Kumar, Surendra P Batra et al. · Biomaterials
|
Apr 2000 |
192 |
| 10 |
Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries
Jeannette E. Davies, Xiufeng Tang, Jeremy W. Denning et al. · European Journal of Neuroscience
|
Mar 2004 |
189 |
| 11 |
Early Treatment with Pegylated Interferon Lambda for Covid-19
Gilmar Reis et al. · New England Journal of Medicine
Open access |
8 Feb 2023 |
179 |
| 12 |
Factors that influence peripheral nerve regeneration: An electrophysiological study of the monkey median nerve
Christian Krarup, Simon J. Archibald, Roger D. Madison · Annals of Neurology
|
3 Dec 2001 |
172 |
| 13 |
Chronic wound prevalence and the associated cost of treatment in Medicare beneficiaries: changes between 2014 and 2019
Marissa Janine Carter, Joan DaVanzo, Randall Haught et al. · Journal of Medical Economics
Open access |
7 Jul 2023 |
167 |
| 14 |
Orthopaedic biofilm infections
Paul Stoodley, Garth D. Ehrlich, Parish Paymon Sedghizadeh et al. · Current Orthopaedic Practice
Open access |
4 Oct 2011 |
163 |
| 15 |
TCDD-Inducible Poly(ADP-ribose) Polymerase: A Novel Response to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Qiang Ma, Kimberly T. Baldwin, Anthony J. Renzelli et al. · Biochemical and Biophysical Research Communications
|
Nov 2001 |
157 |
| 16 |
Integrin α IIb β 3 Inhibitor Preserves Microvascular Patency in Experimental Acute Focal Cerebral Ischemia
Takeo Abumiya, Robert Fitridge, Curt Mazur et al. · Stroke
Open access |
Jun 2000 |
139 |
| 17 |
Development of Near Zero-Order Release Dosage Forms Using Three-Dimensional Printing (3-DP™) Technology
Chen-Chao Wang, Monica R. Tejwani, Willie J. Roach et al. · Drug Development and Industrial Pharmacy
|
2006 |
118 |
| 18 |
An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response
Erin R. Steenblock, Tarek R. Fadel, Michael J. Labowsky et al. · Journal of Biological Chemistry
Open access |
18 Aug 2011 |
111 |
| 19 |
Surgery versus conservative treatment for traumatic acute subdural haematoma: a prospective, multicentre, observational, comparative effectiveness study
Thomas Arjan van Essen et al. · The Lancet Neurology
Open access255 authors |
5 May 2022 |
110 |
| 20 |
A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers
Patrick F. Smith, Janakan Krishnarajah, Philip A. Nunn et al. · British Journal of Clinical Pharmacology
Open access |
21 Jun 2017 |
105 |
| 21 |
Effects of growth-factor-enhanced culture on a chondrocyte-collagen implant for cartilage repair
Brian C. Toolan, Sally R. Frenkel, James M. Pachence et al. · Journal of Biomedical Materials Research
|
Jun 1996 |
105 |
| 22 |
Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa
B. Alexander Yi, Debra Freedholm, Nancy Widener et al. · Journal of Thrombosis and Haemostasis
Open access |
29 Oct 2021 |
104 |
| 23 |
Collagen Conduit Versus Microsurgical Neurorrhaphy: 2-Year Follow-Up of a Prospective, Blinded Clinical and Electrophysiological Multicenter Randomized, Controlled Trial
Michel E. H. Boeckstyns, Allan Ibsen Sørensen, Joaquin Fores Viñeta et al. · The Journal Of Hand Surgery
|
5 Nov 2013 |
103 |
| 24 |
Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India
Alan Hall Jobe, Mark A. Milad, Thomas Peppard et al. · Clinical and Translational Science
Open access |
6 Dec 2019 |
102 |
| 25 |
Engineered cellular response to scaffold architecture in a rabbit trephine defect
Joshua L. Simon, Tithi Dutta Roy, John Russell Parsons et al. · Journal of Biomedical Materials Research Part A
|
14 Jul 2003 |
99 |
| 26 |
Artificial Intelligence and Machine Learning Applied at the Point of Care
Zuzanna Angehrn, Liina Haldna, Anthe S. Zandvliet et al. · Frontiers in Pharmacology
Open access |
18 Jun 2020 |
93 |
| 27 |
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy
James R. Myette, Toshiki Kano, Hitoshi Suzuki et al. · Kidney International
Open access |
16 Mar 2019 |
92 |
| 28 |
Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study
Ellie Hershberger, Susan E. Sloan, Kristin M. Narayan et al. · EBioMedicine
Open access |
9 Jan 2019 |
88 |
| 29 |
Nonlinear Mixed‐Effects Model Development and Simulation Using nlmixr and Related R Open‐Source Packages
Matthew L. Fidler, Justin J. Wilkins, Richard Hooijmaijers et al. · CPT Pharmacometrics & Systems Pharmacology
Open access |
17 Jun 2019 |
85 |
| 30 |
Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters
Brahim Achour, Zubida M. Al‐Majdoub, Agnieszka Grybos‐Gajniak et al. · Clinical Pharmacology & Therapeutics
Open access |
3 Nov 2020 |
84 |
| 31 |
Development of a Multicompartment Permeability‐Limited Lung PBPK Model and Its Application in Predicting Pulmonary Pharmacokinetics of Antituberculosis Drugs
Lu Gaohua, J. R. Wedagedera, Ben G. Small et al. · CPT Pharmacometrics & Systems Pharmacology
Open access |
Oct 2015 |
84 |
| 32 |
The influence of manufacturing procedure on the degradation of poly(lactide-co-glycolide) 85:15 and 50:50 implants
Monica Ramchandani, Marvin C. Pankaskie, Dennis H. Robinson · Journal of Controlled Release
|
1997 |
84 |
| 33 |
Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future
Craig R. Rayner, Patrick F. Smith, David R. Andes et al. · Clinical Pharmacology & Therapeutics
Open access |
9 Feb 2021 |
78 |
| 34 |
Standardized criterion to analyze and directly compare various materials and models for peripheral nerve regeneration
Ioannis V. Yannas, Mei Zhang, Mark H. Spilker · Journal of Biomaterials Science Polymer Edition
|
2007 |
77 |
| 35 |
Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization
John J. Grzesiak, Michael D. Pierschbacher, Mario F. Amodeo et al. · Biomaterials
|
Dec 1997 |
76 |
| 36 |
Safe Tourniquet Use: A Review of the Evidence
Peter G. Fitzgibbons, Christopher W. DiGiovanni, Sayed Hares et al. · Journal of the American Academy of Orthopaedic Surgeons
|
May 2012 |
75 |
| 37 |
Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review
Ranita Kirubakaran, SOPHIE LENA STOCKER, Stefanie Hennig et al. · Clinical Pharmacokinetics
ReviewOpen access |
11 Aug 2020 |
74 |
| 38 |
Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published Models
André Dallmann, Marc Pfister, John van den Anker et al. · Clinical Pharmacology & Therapeutics
Review |
10 Apr 2018 |
72 |
| 39 |
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance
John O. Miners, Thomas M. Polasek, Julie-Ann Hulin et al. · Pharmacology & Therapeutics
|
30 May 2023 |
67 |
| 40 |
Population Pharmacokinetics of Trastuzumab Deruxtecan in Patients With HER2‐Positive Breast Cancer and Other Solid Tumors
Ophelia Q. P. Yin, Yuan Xiong, Seiko Endo et al. · Clinical Pharmacology & Therapeutics
Open access |
29 Oct 2020 |
65 |
| 41 |
Decorin promotes robust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons
Kenneth H. Minor, Xiufeng Tang, Genevieve A. Kahrilas et al. · Neurobiology of Disease
Open access |
27 Jun 2008 |
65 |
| 42 |
Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network
L. Cucurull-Sanchez, Michael John Chappell, Vijayalakshmi Chelliah et al. · CPT Pharmacometrics & Systems Pharmacology
Open access |
23 Jan 2019 |
63 |
| 43 |
Virtual Twins: Understanding the Data Required for Model‐Informed Precision Dosing
Thomas M. Polasek, Amin Rostami‐Hodjegan · Clinical Pharmacology & Therapeutics
|
14 Feb 2020 |
61 |
| 44 |
Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response
Stephanus T. Malherbe et al. · EJNMMI Research
Open access |
10 Feb 2020 |
57 |
| 45 |
Exposure‐Response Relationships in Patients With HER2‐Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan
Ophelia Q. P. Yin, Hiroji Iwata, Chia‐Chi Lin et al. · Clinical Pharmacology & Therapeutics
Open access |
17 May 2021 |
56 |
| 46 |
Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma
Ken Ogasawara, Michael Dodds, Timothy R. Mack et al. · Clinical Pharmacokinetics
Open access |
14 Jun 2021 |
54 |
| 47 |
Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients
Rachael A. Lawson, Christine E. Staatz, Christopher J. Fraser et al. · Clinical Pharmacokinetics
|
30 Oct 2020 |
54 |
| 48 |
Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168)
Timothy D. Owens, Patrick F. Smith, Andrew David Redfern et al. · Clinical and Translational Science
Open access |
Nov 2021 |
53 |
| 49 |
In vitro comparison of wear characteristics of PyroCarbon and metal on bone: Shoulder hemiarthroplasty
Jerome J. Klawitter, Jason Patton, Robert B. More et al. · Shoulder & Elbow
Open access |
11 Sep 2018 |
53 |
| 50 |
Global regulatory registration requirements for collagen-based combination products: points to consider
J.E. O’Grady · Advanced Drug Delivery Reviews
|
22 Oct 2003 |
53 |